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o use appropriate protective clothing (gloves and aprons
r gowns), to intensify environmental cleaning with a chlo-
ine containing disinfectant and to take speciﬁc precautions
or the use of devices (disposable or dedicated to individ-
al patient). Patient isolation must continue at least until
iarrhoea has ceased. Each hospital should have an appro-
riate surveillance system to recognize an increase of the
ncidence of CDI in an early stage. All infection control mea-
ures should be written in a local protocol so that additional
easures can be carried out as soon as a problem with
DI arises. When outbreaks occur, additional recommenda-
ions include a reinforcement of general and hand washing
easures, intensifying of testing patients with diarrhoea
or C. difﬁcile, reinforcement of environmental cleaning,
nformation and education of health-care workers, clean-
ng department and visitors, cohorting of infected patients,
nd eventually closure of the unit followed by intensive
nvironmental cleaning. Restricted antibiotic prescribing
s also highly recommended to reduce polypharmacy and
uration of administration. Second and third generations
ephalosporins and more recently ﬂuoroquinolones have
een identiﬁed as potential risk factors. Although some hos-
itals report successes for enhanced environmental cleaning
ith potentially effective agents such as hydrogen peroxide
apour, the evidence is too scarce to consider this as an
vidence-based approach.
oi:10.1016/j.ijid.2008.05.148
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. fragilis is one of the most abundant gram negative anaer-
bes living symbiotically in the human intestine, where it
igests carbohydrates for the host and has been implicated
n immune system development. It is also an opportunis-
ic pathogen and a reservoir of antibiotic resistance genes.
. fragilis produces multiple capsular polysaccharides and
ucosylated glycoproteins. Mutant strains deﬁcient in pro-
uction of either of these cannot compete with wild-type
n colonization of germ-free mice, indicating that both
ypes of molecule are vital for symbiosis. Here we char-
cterize the molecular biology of the protein glycosylation
ystem. A cell lysate was enriched for glycosylated proteins
y lectin afﬁnity chromatography and proteins identiﬁed
y mass spectrometry. These candidates were expressed
rom a plasmid in B. fragilis with a C-terminal His tag,
uriﬁed and glycosylation conﬁrmed by periodate reactivity
nd release of oligosaccharides. The glycoproteins include
secreted lipoprotein and several soluble periplasmic pro-
eins, the ﬁrst time that the latter has been observed in
bacterial species. Deletion of a genetic region contain-
ng a gene resembling an O-antigen ﬂippase and multiple
i
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lycosyltransferases reduced the MW of the glycoproteins,
ndicating that these genes are involved in protein glycosy-
ation and suggesting that it occurs in the periplasm. The
mallest and most abundant glycoprotein was investigated
n detail. Similar glycans were released by beta-elimination
nd hydrazinolysis, consistent with O-linkage to Ser or
hr. Point mutations in peptides that were rarely or never
bserved by mass spectrometry, and therefore likely to be
lycosylated, identiﬁed one Ser and three Thr residues as
robable glycosylation sites. Deletion of the signal peptide
revented glycosylation of the protein, consistent with it
ccurring in the periplasm. We continue to investigate the
iochemistry and genetics of the glycosylation system, the
iological functions of the glycoproteins and the role of gly-
osylation.
oi:10.1016/j.ijid.2008.05.149
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lthough anaerobes are predominant in humans, largely out-
umbering aerobic bacteria, experimental data concerning
heir bioﬁlm forming ability are still relatively few and
ssentially focused on the anaerobic ﬂora of the mouth
including dental plaque, buccal mucosa and tongue bioﬁlm)
nd the vaginal mucosa.
As the oral environment is concerned, its complexity has
nduced the development of a number of artiﬁcial mouth
odels able to simulate the different conditions of micro-
ial growth within the microcosms of the oral cavity. With
egards to the vaginal mucosa, recent studies have eluci-
ated that the bioﬁlm phenotype confers to Gardnerella
aginalis a survival advantage in the presence of hydrogen
eroxide and lactic acid producing resident lactobacilli; on
he other hand, the ability of probiotic strains of Lactobacil-
us to interfere with Gardnerella vaginalis and disrupt its
ioﬁlm, has been recently reported as a promising tool to
educe the need for antibiotics in the treatment of bacterial
aginosis.
As the intestinal tract is concerned, investigations by
icroscopic and FISH techniques have shown that mucosal
acteria, including bacteroides and biﬁdobacteria, occur
n microcolonies and are distributed throughout the mucus
ayer.
Our group is currently investigating the role of anaerobes
n the occlusion of biliary stents. SEM observations revealed
hat biliary sludge occluding the lumen of the 18 so far
xamined polyethylene stents was constituted by a multi-
pecies (aerobes and anaerobes) microbial bioﬁlm immersed
n an amorphous material containing also dietary ﬁbers and
rystals of bile salts. The ability of the isolated anaerobic
trains, belonging to the species Bacteroides, Clostridium,
usobacterium, Peptostreptococcus, Prevotella and Veil-
onella, to form bioﬁlm has been assessed in vitro. On the
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light of the higher antibiotic-resistance reported in bioﬁlm-
growing bacteria, our ﬁndings on the role of anaerobes in
the occluding process should be considered in selecting and
dosing antibiotics for the prophylaxis of biliary stent block-
age.
doi:10.1016/j.ijid.2008.05.150
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Can Expanded Treatment Slow the AIDS Epidemic?
The Public Health Perspective
N. Kumarasamy
YRGCARE,VHS, Chennai, India
The introduction of antiretroviral therapy has changed the
course of HIV disease by improving survival rates. But ART
has equal potential for prevention, since it reduces the HIV
RNA level and the probability of HIV transmission from an
infected person to their sexual partners. Currently NIH is
undertaking a large randomized clinical trial (HPNT052) in
serodiscordant couples to study the effect of antiretrovi-
ral therapy in preventing HIV transmission to their partner.
Although there have been no randomized controlled clini-
cal trials on the subject, antiretroviral drugs are currently
used in clinical practice for post-exposure prophylaxis after
inadvertent occupational exposure or after sexual exposure
to the virus. The success story in using antiretrovirals for
HIV prevention has been shown from trials involving Mother
to child HIV transmission interventions. Hence Can Expanded
Treatment through the Public Health approach slow the AIDS
Epidemic?
doi:10.1016/j.ijid.2008.05.151
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Can Expanded Treatment Slow the AIDS Epidemic?
The Behavioral Scientist’s View
K. Chillag
CDC, Atlanta, GA, USA
This presentation explores existing and potential behav-
ioral and social science contributions to consideration of
the impacts of expanded antiretroviral (ARV) scale-up on
the global HIV epidemic. Behavioral science literature com-
monly evaluates sexual behavior (‘‘risk compensation’’) and
medication adherence. While such analyses are critical to
evaluation of overall impact and will be reviewed here,
the presenter seeks to highlight approaches and empirical
research that set (and sometimes problematize) such typi-
cally individually-based approaches in their social, cultural,
political, economic, and human-rights/ethical contexts. It,
furthermore, brings behavioral and social science contri-
butions to bear on the critical question of: ‘‘how do we
deﬁne and measure success?’’ The presentation addresses
the ways in which interdisciplinary behavioral and social
science work can illuminate key questions about feasibility
and sustainability as well as ‘‘unintended consequences’’ of
these biomedical interventions on non-biomedical HIV pre-
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ention interventions and social and health systems. From
practical standpoint, such analyses can 1) assist identi-
cation of appropriate methods and criteria to evaluate
mpacts; 2) assist targeting and revision of patient and com-
unity educational materials and involvement strategies;
nd 3) aid development of uptake, retention and medica-
ion and general program adherence schemes that more
xplicitly address economic, cultural, and social barriers.
systematic analysis of lay media (primarily print sources)
bout recent ARV scale-up will be used as a case study
o demonstrate how social/behavioral science perspectives
ay shed light on popular conceptions of such programs and
echnologies, how scientiﬁc information is interpreted by
edia and the general public, and how consequential mis-
onceptions may arise. In the overall presentation, special
mphasis is placed on examination of approaches and per-
pectives that are likely to inform questions and solutions
elevant to both ARV treatment and biomedical prevention
echnologies under testing, particularly implementation of
RV pre-exposure prophylaxis.
oi:10.1016/j.ijid.2008.05.152
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ackground: With the exception of male circumcision and
ome behavioural interventions, randomised controlled tri-
ls (RCTs) of HIV prevention interventions have reported
isappointing results. In this presentation, data on post-
xposure prophylaxis (PEP, the provision of anti-retrovirals
ARVs) after exposure to prevent HIV infection) and
re-exposure prophylaxis (Pre-EP, ARVs provided before
xposure to prevent infection) will be reviewed.
Methods: A guided literature review on the efﬁcacy,
ost-effectiveness, implementation policy and likely public
ealth impact of PEP and pre-EP was conducted.
Results: No RCTs examining the efﬁcacy of PEP were iden-
iﬁed. Nevertheless, a variety of animal and observational
vidence suggests that PEP prescribed within 72 hours of HIV
xposure is likely to substantially reduce the risk of HIV
ransmission. PEP use at the population level is generally
ot cost-effective, unless its use is highly targeted towards
he highest risk exposures. Despite these limitations, poli-
ies recommending PEP after sexual and other HIV exposures
xist in many settings. Although it is possible that post-
P may prevent cases of transmission, a substantial public
ealth impact on the HIV epidemic is unlikely. RCTs eval-
ating the efﬁcacy of Pre-EP are currently underway in a
umber of settings. Animal data strongly suggest that Pre-
P will need to consist of combinations of more than one
RV. The cost effectiveness of Pre-EP will depend strongly
n the risk setting. No locations were identiﬁed which cur-
ently recommend Pre-EP, and there has been little study of
he potential public health impact of this preventive inter-
ention.
Conclusion: PEP is being increasingly utilized as a form of
IV prevention, despite the lack of any efﬁcacy data from
